Should patients with ‘mild’ strokes get tPA?Few receive the clot buster, despite substantial risk of disability Community spirit boosts success of BP programSmall-town volunteerism praised for helping to reduce hospital admissions All participants are winners in hospitals’ health competition Cardiac rehab: Women staying away in droves Patients who would benefit most aren’t going, study shows Fast heart rate a bad sign in congestive heart failure Marathon running hard on the heart MRI scans reveal temporary left ventricular injury Rhythm beats rate control for anxious atrial fib sufferers Study shows personality plays a role in treatment choice Canadian usage of clopidogrel following hospitalization falls short Counselling helps cut abdominal fat Visits to kinesiologist and dietitian help overweight men make needed lifestyle changes Smoking cessation drug has promise in cardiac patients Ottawa researchers also report success with their program for quitting smoking Adverse Reactions: Clopidogrel–PPI interaction revisited Some proton pump inhibitors may be associated with a decrease in the antiplatelet effect of clopidogrel and an increased risk of cardiac events. Adverse Reactions: Sibutramine - increased cardiovascular risks Sibutramine voluntarily withdrawn from Canadian and American markets in October 2010. First Previous 70 71 72 73 74 Next Last
